There’s an Experimental New Vaccine for Melanoma—and We Have Questions
5 Articles
5 Articles
The experimental melanoma vaccine, between expectation and caution due to lack of data as it is a complex trial.
A first experimental messenger RNA vaccine against skin cancer could revolutionize how to treat multiple types of cancer.
Melanoma is the most aggressive skin cancer caused, in the vast majority of cases, by exposure to the sun. An experimental melanoma vaccine, announced by Moderna and Merck pharmaceutical companies, has generated expectation and hope, but it is still early to know details. Moderna and Merck pharmaceutical companies (known as MSD outside the United States and Canada) made their communication in press releases and not in a scientific publication re…
In dialogue with “Ronda de Correspondencias”, Norman Powell, a journalist from the United States, explained the advances of an experimental melanoma vaccine based on messenger RNA technology used during the COVID-19 pandemic. Read more
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
